OpenAlex
PricingAboutJobs
Log inGet started
Work

A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer

HTML

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Urology
DOI: 10.1016/j.eururo.2012.09.008
Authors: Christopher C. Parker, Sarah Pascoe, Aleš Chodacki, Joe M. O'Sullivan, Josep R. Germá, Charles Gillies O’Bryan-Tear, Trond Haider, Peter Hoskin
Institutions: Royal Marsden Hospital, Derriford Hospital, Hospital Jihlava, Queen's University Belfast, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Mount Vernon Hospital
Language: English

Topic: Prostate Cancer Treatment and Research
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: castration-resistant prostate cancer, bone metastasis, dose-response relationship, alkaline phosphatase, skeletal-related events, pain, treatment-related adverse events, radiopharmaceutical therapy, quality of life, survival, anemia, diarrhea, nausea, hematologic toxicity
SDG: Good health and well-being

Open Access status: closed

Funder: Bayer HealthCare
OpenAlex ID: W2135375304
FWCI: 6.21
Cites: 29
Cited by: 197
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms